Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Healthy volunteers needed for CBD research – JHU Hub – Johns Hopkins University
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Cannabidiol Fragile X Trial Fails to Meet Primary Endpoint – Hemp Gazette
Recent cannabidiol fragile x syndrome trial results demonstrate the challenges of translating preclinical cannabis research into effective treatments for neurodevelopmental disorders. This clinical analysis examines what the trial failure means for…
Minnesota Legislature Passes Omnibus Cannabis Bill Restructuring Medical and Adult-Use …
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by …
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Clinical Trial: Marijuana Oil With THC and CBD May Reduce Pain and Improve Sleep in …
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
New York’s cannabis regulator wants to ease IBD symptoms with THC and CBD in new study – AMNY
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
New York Launches First State-Led Cannabis Study On CBD, THC, And IBD Patients
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Exploring the Growing Trust in Cannabidiol Oil – The Assam Tribune
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Genetic Link Between Cannabis Use and Psychosis Could Help Identify Those Most at Risk
Emerging genetic risk cannabis psychosis profiles help clinicians identify patients vulnerable to cannabis-induced psychosis. This allows for more targeted counseling and personalized risk assessment. Understanding genetic risk cannabis psychosis…